Marinus Pharmaceuticals, Inc.
Marinus Pharmaceuticals, Inc. (MRNS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · MRNS · as of Jun 10, 2026
Key Statistics
Explore Marinus Pharmaceuticals, Inc. Data
mrns stock data · financialsAbout Marinus Pharmaceuticals, Inc.
Marinus Pharmaceuticals, Inc. is a specialized biopharmaceutical firm dedicated to the development and commercialization of therapeutic solutions for individuals suffering from rare genetic epilepsies…
what is marinus pharmaceuticals, inc. · mrns stock overview · marinus pharmaceuticals, inc. company profile · who is marinus pharmaceuticals, inc. ceo · mrns NASDAQ · marinus pharmaceuticals, inc. headquarters · marinus pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Marinus Pharmaceuticals, Inc. (MRNS) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jul 31, 2014. As of the latest trading session, MRNS stock price is $0.55, with a market capitalization of $30.4M. The stock has returned — over the past 12 months and — year-to-date.
Frequently Asked Questions
As of the latest trading session, Marinus Pharmaceuticals, Inc. (MRNS) stock price is $0.55. The stock is traded on NASDAQ under the ticker symbol MRNS. The 52-week range is $0.22 – $10.50.